Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Valerie Lehnert"'
Autor:
Peter B. Jones, Valerie Lehnert, Judith Anzures-Cabrera, Ruchi Upmanyu, Josef Stasek, Gabriela Suchankova, Kausik K. Ray, Marc Ditmarsch, Eric J. Niesor, David Kallend, Maarten W. J. van Hessen, Meike Pauly-Evers, Ingar Holme
Publikováno v:
European Heart Journal. 35:1792-1800
Aims The effects of cholesteryl ester transfer protein (CETP) inhibition on lipids, inflammation, and markers of high-density lipoprotein (HDL) function, following an acute coronary syndrome (ACS), are unknown. Methods and results The dal-ACUTE study
Publikováno v:
RNA
RNA, Cold Spring Harbor Laboratory Press, 2004, 10 (2), pp.176-84
RNA, Cold Spring Harbor Laboratory Press, 2004, 10 (2), pp.176-84
The class I ligase ribozyme catalyzes a Mg++-dependent RNA-ligation reaction that is chemically analogous to a single step of RNA polymerization. Indeed, this ribozyme constitutes the catalytic domain of an accurate and general RNA polymerase ribozym
Autor:
Dorothee Foernzler, Michael Ott, James Holzwarth, Valerie Lehnert, A. Thompson, Sabine Demmak
Publikováno v:
Human Mutation. 17:243-254
The discovery of single nucleotide polymorphisms ( SNPs) is currently pursued with a tremendous effort. SNPs represent a rich source for molecular markers, since estimations predict six to seven million of these DNA variations in the human genome. A
Publikováno v:
Chemistry & Biology. 3(12):993-1009
Background : Group I introns self-splice via two consecutive trans-esterification reactions in the presence of guanosine cofactor and magnesium ions. Comparative sequence analysis has established that a catalytic core of about 120 nucleotides is cons
Publikováno v:
Cell. 87:1135-1145
The Neurospora crassa mitochondrial (mt) tyrosyl-tRNA synthetase (CYT-18 protein) functions in splicing group I introns, in addition to aminoacylating tRNA Tyr . Here, we compared the CYT-18 binding sites in the N. crassa mt LSU and ND1 introns with
Autor:
David Kallend, Juan Carlos Kaski, Valerie Lehnert, Thomas Münzel, John J.P. Kastelein, Thomas F. Lüscher, Eric de Groot, Stefano Taddei, Tracy Burgess, John E. Deanfield, Raphaël Duivenvoorden, J. Wouter Jukema
Publikováno v:
Current Medical Research and Opinion, 27(1), 141-150
Current medical research and opinion, 27(1), 141-150. Taylor and Francis Ltd.
Current medical research and opinion, 27(1), 141-150. Taylor and Francis Ltd.
Dalcetrapib increases high-density lipoprotein cholesterol (HDL-C) levels through effects on cholesteryl ester transfer protein (CETP). As part of the dalcetrapib dal-HEART clinical trial programme, the efficacy and safety of dalcetrapib is assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c4ad5a9b80072c971eabf19a8475ea
https://hdl.handle.net/1887/109014
https://hdl.handle.net/1887/109014
Publikováno v:
Appetite. 22(2)
Effects of palatability on the meal as a whole or the microstructure of meals are often inconsistent or even divergent. Is this attributable to the nature of the test meals? In the present study, three frequently used types of meals were offered to s